Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

June 21, 2017 - FDA

• FDA Briefing Information for the June 21, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 21, 2017 - Apexigen, Inc.

• Apexigen Briefing Information for the June 21, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 21, 2017 - Pharma Mar USA, Inc.

• Pharma Mar Briefing Information for the June 21, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 21, 2017 - Astellas Pharma Global Development, Inc.

• Astellas Briefing Information for the June 21, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 22, 2017 - FDA

• FDA Briefing Information for the June 22, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee
• Errata to the FDA Briefing Information for the June 22, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 22, 2017 - Eli Lilly and Company

• Eli Lilly Briefing Information, Olaratumab, for the June 22, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee
• Eli Lilly Briefing Information, Prexasertib, for the June 22, 2017 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee